Loading
Latest filing published 23 Oct 2026 for 에이프릴바이오.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
차상훈 discloses dealings in 에이프릴바이오 to DART (FSS). We count 6 filings; the first trade dates from 1 July 2026 and the latest from 23 October 2026.
Market trades split into 1 purchase and 1 sale. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 23 October 2026, reports a transaction in 에이프릴바이오. The most recent open-market purchase was published on 29 July 2026, 88 days ago. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.